Close Menu

NEW YORK (GenomeWeb) – Fulgent Genetics reported after the close of the market on Monday that its second quarter revenues grew 17 percent year over year as billable tests delivered during the quarter climbed 47 percent.

For the three months ended June 30, Fulgent posted $5.4 million in revenues, up from $4.6 million in Q2 2017. The number of billable tests delivered during the recently completed quarter reached 5,700, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Nov
14
Sponsored by
Qiagen

This webinar will discuss some of the issues laboratories face when transitioning to next-generation sequencing, and the key features to be considered for a successful implementation in routine testing.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.